ArticleHeliyon2025
The effect of silver nitrate on the alkaline phosphatase activity, TNF and IL-10 gene expression; Experimental and computational studies.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study examines the effects of silver nitrate on the activity of the enzyme alkaline phosphatase (ALP) and its regulatory influence on inflammatory cytokines, specifically interleukin-10 (IL-10) and tumor necrosis factor-alpha (TNF-α). These parameters are critical for elucidating the biochemical and immunological responses associated with metal exposure. The research employed enzyme-linked immunosorbent assay (ELISA) techniques to quantify IL-10 and TNF-α levels using serum assay kits. Additionally, gel filtration chromatography with Sephacryl S300 demonstrated that serum from silver nitrate-treated groups exhibited a significantly elevated concentration of high molecular weight alkaline phosphatase compared to control groups. In the TNF-α ELISA assay, no significant differences were observed between the control and treatment groups 15 days post-injection of silver nitrate. However, a statistically significant alteration was detected in both groups 45 days post-injection (P < 0.005). Molecular docking analysis further revealed that the optimal binding pose for ALP, based on the docking score, was -5.28 kcal/mol, with a re-ranking score of -7.43 kcal/mol. Collectively, the findings indicate that silver nitrate exerts a significant impact on ALP activity, leading to a sustained increase in TNF-α levels over time, while IL-10 levels remain unaffected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.